Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-β-catenin axis.
Munmun PandaStuti BiswalBijesh Kumar BiswalPublished in: Molecular biology reports (2024)
The combination of evodiamine and cisplatin may be a novel strategy for combating cisplatin resistance in NSCLC.